ACLS
Axcelis Technologies·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 0
Consensus Rating "Strong Buy"
Ample Liquidity
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ACLS
Axcelis Technologies, Inc.
A leading supplier of enabling ion implantation solutions for the semiconductor industry
Semiconductor Products and Equipment
--
07/11/2000
NASDAQ Stock Exchange
1,524
12-31
Common stock
108 Cherry Hill Drive, Beverly, Massachusetts 01915
--
Axcelis Technologies, Inc., is dedicated to the design, manufacture and service of ion implantation, dry wafer and other processing equipment for the manufacture of semiconductor chips. The company sells to the world's leading semiconductor chip makers. In addition to equipment, Axcelis provides extensive after-sales service and support, including spare parts, equipment upgrades, maintenance services and customer training. Axcelis was incorporated in Delaware in 1995 and is headquartered in Beverly, Massachusetts.
Earnings Call
Company Financials
EPS
ACLS has released its 2025 Q3 earnings. EPS was reported at 1.21, versus the expected 1, beating expectations. The chart below visualizes how ACLS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ACLS has released its 2025 Q3 earnings report, with revenue of 213.61M, reflecting a YoY change of -16.74%, and net profit of 25.99M, showing a YoY change of -46.50%. The Sankey diagram below clearly presents ACLS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


